Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2014 Jan 7;143(3):485–492. doi: 10.1007/s10549-013-2827-0

Table 4.

23 cases with locally equivocal IHC for determination of HER2 positivity (shaded cells indicate discordance between central laboratories)

Mayo central
HER2 negative HER2 positive

IEO central IHC neg / FISH neg IHC equ / FISH neg IHC equ / FISH equ IHC equ / FISH pos IHC pos / FISH pos Total
HER2 negative
    IHC neg / FISH neg 3 3 -- 1 -- 7
    IHC equ / FISH neg -- 1 -- 1 -- 2
    IHC equ / FISH equ -- -- -- 2 1 3
HER2 positive
    IHC equ / FISH pos -- 1 -- 1 3 5
    IHC pos / FISH pos -- -- -- -- 6 6
Total 3 5 0 5 10 23

IHC immunohistochemical, HER2 human epidermal growth factor receptor 2, FISH fluorescent in situ hydridization, Mayo Mayo Clinic central laboratory, IEO European Institute of Oncology central laboratory, neg negative, equ equivocal, pos positive